Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV16 Associated Cervical Cancer”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Early research (Phase 1)Ended earlyNCT01493154
What this trial is testing

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Early research (Phase 1)Study completedNCT02379520
What this trial is testing

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more
Baylor College of Medicine 32
Early research (Phase 1)Study completedNCT02405221
What this trial is testing

Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer

Who this might be right for
HPV16 Associated Cervical Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Large-scale testing (Phase 3)Study completedNCT00929526
What this trial is testing

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 752
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Not applicableEnded earlyNCT05061940
What this trial is testing

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Who this might be right for
Head and Neck CancerMelanomaHPV-Related Malignancy+5 more
Repertoire Immune Medicines 22
Early research (Phase 1)Looking for participantsNCT06589609
What this trial is testing

Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (SCC)
BlueSky Immunotherapies GmbH 12
Not applicableLooking for participantsNCT07281599
What this trial is testing

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

Who this might be right for
HPV InfectionHPV 16 InfectionHigh Risk HPV+8 more
Qurasense 450
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06273553
What this trial is testing

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

Who this might be right for
Human Papillomavirus Associated Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2/3Human Papillomavirus Type 16 Infection+1 more
RinuaGene Biotechnology Co., Ltd. 39
Testing effectiveness (Phase 2)Looking for participantsNCT07172256
What this trial is testing

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

Who this might be right for
Head and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell CarcinomaNew Diagnosis Tumor+1 more
Yale University 30
Testing effectiveness (Phase 2)Study completedNCT04369937
What this trial is testing

HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma

Who this might be right for
HPV-Related Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Dan Zandberg 18
Testing effectiveness (Phase 2)Study completedNCT02280811
What this trial is testing

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Who this might be right for
Vaginal CancerCervical CancerAnal Cancer+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07090174
What this trial is testing

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

Who this might be right for
HPV Associated CancersHIV (Human Immunodeficiency Virus)Anal Cancer+2 more
Weill Medical College of Cornell University 27
Testing effectiveness (Phase 2)Looking for participantsNCT05686226
What this trial is testing

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Who this might be right for
Cervical CancerThroat CancerOropharynx Cancer+18 more
Christian Hinrichs 20
Early research (Phase 1)Ended earlyNCT04672980
What this trial is testing

RTX-321 Monotherapy in Patients With HPV 16+ Tumors

Who this might be right for
Cervical CancerHead and Neck CancerAnal Cancer
Rubius Therapeutics 9
Testing effectiveness (Phase 2)Looking for participantsNCT07209189
What this trial is testing

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 75
Not applicableStudy completedNCT04064515
What this trial is testing

CTCs in Cervix Cancer

Who this might be right for
Cervical CancerHPV
NYU Langone Health 4
Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996523
What this trial is testing

Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (SCC)
National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Study completedNCT00128661
What this trial is testing

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

Who this might be right for
Cervical CancerPrecancerous Condition
GlaxoSmithKline 7,466
Load More Results